Literature DB >> 10503875

Strain-specific differences in formation of apoptotic DNA ladders in MCF-7 breast cancer cells.

J L Gooch1, D Yee.   

Abstract

We tested the ability of seven MCF-7 strains to undergo DNA fragmentation, as measured by DNA laddering, following doxorubicin-induced apoptosis. Four strains were found to undergo DNA laddering while three were not. All strains were inhibited by doxorubicin, although sensitivity differed. Finally, we show by detection of sub-G1 DNA that doxorubicin induced the same fold increase in apoptosis in MCF-7-ATCC, which did not ladder, and MCF-7-MG, which did ladder. Therefore, detection of DNA ladders is not an accurate indicator of apoptosis in MCF-7 cells as fragmentation of DNA appears to vary between strains.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10503875     DOI: 10.1016/s0304-3835(99)00208-6

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  17 in total

1.  Cytolytic effects and apoptosis induction of Newcastle disease virus strain AF2240 on anaplastic astrocytoma brain tumor cell line.

Authors:  Rola Ali; Aied M Alabsi; Abdul Manaf Ali; Aini Ideris; Abdul Rahman Omar; Khatijah Yusoff; Riyadh Saif-Ali
Journal:  Neurochem Res       Date:  2011-06-14       Impact factor: 3.996

2.  Novel hydrophilic docetaxel (CQMU-0519) analogue inhibits proliferation and induces apoptosis in human A549 lung, SKVO3 ovarian and MCF7 breast carcinoma cell lines.

Authors:  N J S Fauzee; Y-L Wang; Z Dong; Q-G Li; T Wang; M T Mandarry; L Xu; J Pan
Journal:  Cell Prolif       Date:  2012-06-05       Impact factor: 6.831

3.  Cytotoxic effect of achatinin(H) (lectin) from Achatina fulica against a human mammary carcinoma cell line (MCF7).

Authors:  Indra Dharmu; N Ramamurty; Ramalingam Kannan; Mary Babu
Journal:  In Vitro Cell Dev Biol Anim       Date:  2007-09-18       Impact factor: 2.416

4.  The combination of baicalin and baicalein enhances apoptosis via the ERK/p38 MAPK pathway in human breast cancer cells.

Authors:  Qian-mei Zhou; Song Wang; Hui Zhang; Yi-yu Lu; Xiu-feng Wang; Yoshiharu Motoo; Shi-bing Su
Journal:  Acta Pharmacol Sin       Date:  2009-12       Impact factor: 6.150

5.  Proteomic analysis of the vitamin C effect on the doxorubicin cytotoxicity in the MCF-7 breast cancer cell line.

Authors:  Peter Bober; Michal Alexovic; Ivan Talian; Zuzana Tomkova; Zuzana Viscorova; Maria Benckova; Igor Andrasina; Rachele Ciccocioppo; Daniel Petrovic; Mariusz Adamek; Peter Kruzliak; Jan Sabo
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-12       Impact factor: 4.553

6.  Growth inhibition, G(1)-arrest, and apoptosis in MCF-7 human breast cancer cells by novel highly lipophilic 5-fluorouracil derivatives.

Authors:  Juan Antonio Marchal; Houria Boulaiz; Inés Suárez; Estrella Saniger; Joaquín Campos; Esmeralda Carrillo; José Prados; Miguel Angel Gallo; Antonio Espinosa; Antonia Aránega
Journal:  Invest New Drugs       Date:  2004-11       Impact factor: 3.850

7.  Cyto/Genotoxicity study of polyoxyethylene (20) sorbitan monolaurate (tween 20).

Authors:  Morteza Eskandani; Hamed Hamishehkar; Jafar Ezzati Nazhad Dolatabadi
Journal:  DNA Cell Biol       Date:  2013-07-11       Impact factor: 3.311

8.  Effects of newcastle disease virus strains AF2240 and V4-UPM on cytolysis and apoptosis of leukemia cell lines.

Authors:  Aied M Alabsi; Siti Aishah Abu Bakar; Rola Ali; Abdul Rahman Omar; Mohd Hair Bejo; Aini Ideris; Abdul Manaf Ali
Journal:  Int J Mol Sci       Date:  2011-11-30       Impact factor: 5.923

9.  Apoptotic mechanisms in T47D and MCF-7 human breast cancer cells.

Authors:  L M Mooney; K A Al-Sakkaf; B L Brown; P R M Dobson
Journal:  Br J Cancer       Date:  2002-10-07       Impact factor: 7.640

10.  Antioxidant activity of Coriandrum sativum and protection against DNA damage and cancer cell migration.

Authors:  Esther L H Tang; Jayakumar Rajarajeswaran; Shin Yee Fung; M S Kanthimathi
Journal:  BMC Complement Altern Med       Date:  2013-12-09       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.